AGP Executive Report
Last update: 4 hours agoSEC scrutiny on private-investment SPVs: The SEC is pressing advisers to prove their special purpose vehicles actually own or have exposure to startup shares, after reports that some products may overstate access to private-company investments. Biotech M&A: Eli Lilly agreed to buy Merida Biosciences for up to about $2.88B, betting on targeted therapies for autoimmune and allergic disorders. AI market sentiment check: A Reuters-linked recap highlights Jensen Huang’s “buy at a discount” message during Nvidia’s sell-off, with investors weighing whether the call beat a broader AI basket. Prediction-market funding: Polymarket reportedly raised $300M from 1789 Capital (Donald Trump Jr.’s fund) as regulators intensify pressure on prediction sites. Canada foreign-investment push: Prime Minister Mark Carney named Dominic Barton to lead Invest in Canada, aiming to attract more capital while drawing renewed political debate. State tech matching grants: New Mexico opened applications for grants that match outside investment for tech and research, using $150M for R&D and deployment. Investor legal deadlines: Rosen Law flagged multiple securities class-action lead-plaintiff deadlines, including Bloom Energy (Sept. 28) and EquipmentShare (Sept. 21). Corporate updates: Johnson & Johnson set an Oct. 13 investor call for Q3 results; Salesforce eased investor concerns with its latest update.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
